These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 23319019)

  • 21. Colchicine: its mechanism of action and efficacy in crystal-induced inflammation.
    Nuki G
    Curr Rheumatol Rep; 2008 Jul; 10(3):218-27. PubMed ID: 18638431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-interleukin-1 therapy in the management of gout.
    Schlesinger N
    Curr Rheumatol Rep; 2014 Feb; 16(2):398. PubMed ID: 24407823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study.
    Schlesinger N; Mysler E; Lin HY; De Meulemeester M; Rovensky J; Arulmani U; Balfour A; Krammer G; Sallstig P; So A
    Ann Rheum Dis; 2011 Jul; 70(7):1264-71. PubMed ID: 21540198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Colchicine-responsive protracted gouty arthritis with systemic inflammatory reactions.
    Nonaka F; Migita K; Haramura T; Sumiyoshi R; Kawakami A; Eguchi K
    Mod Rheumatol; 2014 May; 24(3):540-3. PubMed ID: 24533551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of interleukin-1 and the inflammasome in gout: implications for therapy.
    Pope RM; Tschopp J
    Arthritis Rheum; 2007 Oct; 56(10):3183-8. PubMed ID: 17907163
    [No Abstract]   [Full Text] [Related]  

  • 26. Mice with miR-146a deficiency develop severe gouty arthritis via dysregulation of TRAF 6, IRAK 1 and NALP3 inflammasome.
    Zhang QB; Qing YF; Yin CC; Zhou L; Liu XS; Mi QS; Zhou JG
    Arthritis Res Ther; 2018 Mar; 20(1):45. PubMed ID: 29544526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Challenges associated with the management of gouty arthritis in patients with chronic kidney disease: a systematic review.
    Curiel RV; Guzman NJ
    Semin Arthritis Rheum; 2012 Oct; 42(2):166-78. PubMed ID: 22560299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of intervention treatment by "heat-clearing and diuresis-promoting" prescription on NALP3, an inflammatory factor in acute gouty arthritis.
    Yu J; Li L; Liu J; Chen Z
    J Orthop Surg Res; 2022 Mar; 17(1):162. PubMed ID: 35292055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Total saponin of Dioscorea collettii attenuates MSU crystal‑induced inflammation via inhibiting the activation of the NALP3 inflammasome and caspase‑1 in THP‑1 macrophages.
    Wang L; Zhu L; Duan C; Li L; Chen G
    Mol Med Rep; 2020 Jun; 21(6):2466-2474. PubMed ID: 32236574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of Xixiancao (Herba Siegesbeckiae Orientalis) on interactions between nuclear factor kappa-B and inflammatory cytokines in inflammatory reactions of rat synovial cells induced by sodium urate.
    Wang Z; Fan X; Xu Y; Chen K; Yu X; Sun G
    J Tradit Chin Med; 2020 Oct; 40(5):774-781. PubMed ID: 33000578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. P2X7R: a potential key regulator of acute gouty arthritis.
    Tao JH; Zhang Y; Li XP
    Semin Arthritis Rheum; 2013 Dec; 43(3):376-80. PubMed ID: 23786870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Canakinumab: a guide to its use in acute gouty arthritis flares.
    Lyseng-Williamson KA
    BioDrugs; 2013 Aug; 27(4):401-6. PubMed ID: 23649936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct Binding to NLRP3 Pyrin Domain as a Novel Strategy to Prevent NLRP3-Driven Inflammation and Gouty Arthritis.
    Yang G; Lee HE; Moon SJ; Ko KM; Koh JH; Seok JK; Min JK; Heo TH; Kang HC; Cho YY; Lee HS; Fitzgerald KA; Lee JY
    Arthritis Rheumatol; 2020 Jul; 72(7):1192-1202. PubMed ID: 32134203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Should patients with interval gout be treated with urate lowering drugs?
    Fam AG
    J Rheumatol; 1995 Sep; 22(9):1621-3. PubMed ID: 8523333
    [No Abstract]   [Full Text] [Related]  

  • 35. Ameliorative Effects of Cardamonin on Monosodium Urate-Induced Gouty Arthritis through Inhibiting NLRP3 Inflammasome Mediation.
    Wang CC; Lu JW; Peng YJ; Lee CH; Lee HS; Chu YH; Huang CJ; Ho YJ; Liu FC; Wu CC
    Medicina (Kaunas); 2021 Aug; 57(9):. PubMed ID: 34577821
    [No Abstract]   [Full Text] [Related]  

  • 36. [The etiology and management of gout].
    Pazár Maldonado B; So A
    Z Rheumatol; 2012 Feb; 71(2):127-36; quiz 137. PubMed ID: 22370804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trikatu, a herbal compound that suppresses monosodium urate crystal-induced inflammation in rats, an experimental model for acute gouty arthritis.
    Murunikkara V; Rasool M
    Cell Biochem Funct; 2014 Jan; 32(1):106-14. PubMed ID: 23674350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gouty Arthritis: A Review of Acute Management and Prevention.
    Wilson L; Saseen JJ
    Pharmacotherapy; 2016 Aug; 36(8):906-22. PubMed ID: 27318031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Jia-Wei-Si-Miao-Wan alleviates acute gouty arthritis by targeting NLRP3 inflammasome.
    Yuan X; Fan YS; Xu L; Xie GQ; Feng XH; Qian K
    J Biol Regul Homeost Agents; 2019 Jan-Feb,; 33(1):63-71. PubMed ID: 30697988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-inflammatory effects of traditional mixed extract of medicinal herbs (MEMH) on monosodium urate crystal-induced gouty arthritis.
    Nam JS; Jagga S; Sharma AR; Lee JH; Park JB; Jung JS; Lee SS
    Chin J Nat Med; 2017 Aug; 15(8):561-575. PubMed ID: 28939019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.